MA24421A1 - Nouvelle application therapeutique de derives du pyrrole. - Google Patents

Nouvelle application therapeutique de derives du pyrrole.

Info

Publication number
MA24421A1
MA24421A1 MA24895A MA24895A MA24421A1 MA 24421 A1 MA24421 A1 MA 24421A1 MA 24895 A MA24895 A MA 24895A MA 24895 A MA24895 A MA 24895A MA 24421 A1 MA24421 A1 MA 24421A1
Authority
MA
Morocco
Prior art keywords
new therapeutic
therapeutic application
pyrrole derivatives
pyrrole
derivatives
Prior art date
Application number
MA24895A
Other languages
English (en)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of MA24421A1 publication Critical patent/MA24421A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA24895A 1996-12-12 1997-12-10 Nouvelle application therapeutique de derives du pyrrole. MA24421A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615287A FR2757059B1 (fr) 1996-12-12 1996-12-12 Nouvelle application therapeutique des derives du pyrrole

Publications (1)

Publication Number Publication Date
MA24421A1 true MA24421A1 (fr) 1998-07-01

Family

ID=9498603

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24895A MA24421A1 (fr) 1996-12-12 1997-12-10 Nouvelle application therapeutique de derives du pyrrole.

Country Status (6)

Country Link
AU (1) AU5487298A (fr)
FR (1) FR2757059B1 (fr)
MA (1) MA24421A1 (fr)
TN (1) TNSN97203A1 (fr)
WO (1) WO1998025612A1 (fr)
ZA (1) ZA9711168B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020506A1 (es) 2000-08-22 2002-07-09 Glaxo Group Ltd Derivados de pirazol fusionados como inhibidores de la proteina cinasa
EP1377573B1 (fr) 2000-12-15 2005-07-27 Glaxo Group Limited Derives de pyrazolopyridine
ES2245380T3 (es) 2000-12-15 2006-01-01 Glaxo Group Limited Pirazolopiridinas.
US7153855B2 (en) 2001-03-08 2006-12-26 Smithkline Beecham Corporation Pyrazolopyridinyl pyrimidine therapeutic compounds
EP1372643A1 (fr) 2001-03-30 2004-01-02 Smithkline Beecham Corporation Pyralopyridines, leur procede de preparation et leur utilisation en tant que composes therapeutiques
JP4219171B2 (ja) 2001-04-10 2009-02-04 スミスクライン ビーチャム コーポレーション 抗ウイルス性ピラゾロピリジン化合物
AU2002305143A1 (en) 2001-04-27 2002-11-11 Smithkline Beecham Corporation Pyrazolo'1,5-a!pyridine derivatives
KR20040018281A (ko) 2001-06-21 2004-03-02 스미스클라인 비참 코포레이션 포진 바이러스 감염의 예방 및 치료를 위한 이미다조[1，２－α]피리딘 유도체
US7244740B2 (en) 2001-10-05 2007-07-17 Smithkline Beecham Corporation Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
WO2003050120A1 (fr) * 2001-12-11 2003-06-19 Smithkline Beecham Corporation Derives de la pyrazolo-pyridine, agents anti-herpes
WO2004033454A1 (fr) 2002-10-03 2004-04-22 Smithkline Beecham Corporation Composes therapeutiques a base de derives de pyrazolopyridine
GB0816759D0 (en) * 2008-09-12 2008-10-22 Selcia Ltd Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2557111B1 (fr) * 1983-12-21 1986-04-11 Rhone Poulenc Sante Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent
DE4129779A1 (de) * 1991-09-07 1993-03-11 Boehringer Mannheim Gmbh Neue tricyclische thiazol- und oxazol-derivate und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
FR2757059A1 (fr) 1998-06-19
TNSN97203A1 (fr) 2005-03-15
AU5487298A (en) 1998-07-03
WO1998025612A1 (fr) 1998-06-18
FR2757059B1 (fr) 1999-01-29
ZA9711168B (en) 1998-06-15

Similar Documents

Publication Publication Date Title
EE9800227A (et) 17ß-karboksü-, karbotio- ja amiidandrostaanide laktoonderivaadid
BR9507179A (pt) Derivados de 3-aril-4-hidróxi-delta3-dihidrotiofena
PT833828E (pt) Derivados de rapamicina
BR9612201A (pt) Derivados da tirosina
DE69611361D1 (de) Chinazolin-derivate
DE69522717D1 (de) Chinazolinderivate
DE69610698D1 (de) Chinazolin-derivate
MA23815A1 (fr) Derives de n-(3-benzofuranyl)-uree
PT907364E (pt) Composicao farmaceutica de libertacao sustida
BR9611834A (pt) Derivados de oximetóxi-3-aril-pirona
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
DE69601527D1 (de) Pyrrolylbenzimidazol-Derivate
ATA100695A (de) Prothrombin-derivate
FR2757059B1 (fr) Nouvelle application therapeutique des derives du pyrrole
PT856007E (pt) Derivados de ciclopeptidos
FR2727680B1 (fr) Nouveaux derives de 5-pyrrolyl-6-halogeno-2- pyridylmethylsufinylbenzimidazole
BR9610597A (pt) Derivados de diarilalcenilamina
DE69627830D1 (de) Pyrazol-derivate
BR9607046A (pt) Derivados de 3-pirrolidiliden-2-ona-cefalosporinas
BR9607396A (pt) Derivados de isoxazola
DK0723963T3 (da) 4-Amino-benzoylguanidin-derivater
ATE177102T1 (de) Chromanderivate
DE59610106D1 (de) Fluorbenzylether-Derivate
BR9609723A (pt) Derivados da tricetona
FR2735476B1 (fr) Nouvelle application de derives du pyrrole